Northwest Biotherapeutics Capital Limited

DataGardener
live
Micro

Northwest Biotherapeutics Capital Limited

09103328•Private Limited With Share Capital

C/O Clyde & Co Llp,,, St Botolph Building, 138 Houndsd, London, EC3A7AR
Incorporated

26/06/2014

Company Age

12 years

Directors

1

Employees

—

SIC Code

68100

Risk

low risk

Company Overview

Registration, classification & business activity

Northwest Biotherapeutics Capital Limited (09103328) is a private limited with share capital incorporated on 26/06/2014 (12 years old) and registered in london, EC3A7AR. The company operates under SIC code 68100 - buying and selling of own real estate.

Private Limited With Share Capital
SIC: 68100
Micro
Incorporated 26/06/2014
EC3A7AR

Financial Overview

Total Assets

£19.21M

Liabilities

£20.87M

Net Assets

£-1.66M

Est. Turnover

£630.0K

AI Estimated
Unreported
Cash

£38.0K

Key Metrics

1

Directors

1

Shareholders

Board of Directors

1

Charges

5

Registered

4

Outstanding

0

Part Satisfied

1

Satisfied

Risk Assessment

low risk

International Score

Future Factor

fair

Performance Rating

Accounts

Typetotal exemption full
Due Date30/09/2027
Filing Date30/09/2026
Latest Accounts31/12/2025

Trading Addresses

The St. Botolph Building, 138 Houndsditch, London, EC3A7ARRegistered

Related Companies

2

Contact

C/O Clyde & Co Llp,,, St Botolph Building, 138 Houndsd, London, EC3A7AR